EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Risk Analysis of Eculizumab-Related Meningococcal Disease in Japan Using the Japanese Adverse Drug Event Report Database

Yumi Matsumura

Drug, Healthcare and Patient Safety · 2020-11 · Volume 12 · 207-215

DOI: 10.2147/dhps.s257009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug, Healthcare and Patient Safety, 2020-11. Verfasst von Yumi Matsumura. Beteiligte Einrichtung: Department of Patient Safety, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Neisseria meningitidiscase-fatality rateincidencemortality ratepost-marketing surveillancerisk communication

Autor:innen und Institutionen

  • Department of Patient Safety, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan.

Zitieren

APA

Matsumura, Y. (2020). Risk Analysis of Eculizumab-Related Meningococcal Disease in Japan Using the Japanese Adverse Drug Event Report Database. Drug, Healthcare and Patient Safety, Volume 12, 207-215. https://doi.org/10.2147/dhps.s257009

Vancouver

Matsumura Y. Risk Analysis of Eculizumab-Related Meningococcal Disease in Japan Using the Japanese Adverse Drug Event Report Database. Drug, Healthcare and Patient Safety. 2020;Volume 12:207-215. doi:10.2147/dhps.s257009

BibTeX
@article{Matsumura2020,
  author = {Matsumura, Yumi},
  title = {Risk Analysis of Eculizumab-Related Meningococcal Disease in Japan Using the Japanese Adverse Drug Event Report Database},
  journal = {Drug, Healthcare and Patient Safety},
  year = {2020},
  volume = {Volume 12},
  pages = {207--215},
  doi = {10.2147/dhps.s257009}
}
Kostenlos starten →